Esperion Therapeutics Inc. (ESPR) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Esperion Therapeutics Inc...

    NASDAQ: ESPR · Real-Time Price · USD
    3.30
    0.40 (13.79%)
    At close: Oct 03, 2025, 3:59 PM
    3.32
    0.61%
    Pre-market: Oct 06, 2025, 07:03 AM EDT

    Esperion Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -7.96 -1.47 -1.44 -0.45
    PEG Ratio
    		 0.09 0.03 0.02 -0.01
    PS Ratio
    		 1.24 2.65 5.48 1.84
    PB Ratio
    		 -1.06 -0.68 -0.31 -0.13
    P/FCF Ratio
    		 -17.18 -2.28 -2.37 -0.55
    P/OCF Ratio
    		 -17.41 -2.28 -2.37 -0.55
    OCF/S Ratio
    		 -0.07 -1.16 -2.32 -3.36
    Debt / Equity Ratio
    		 -1.52 -1.19 -0.19 -0.24
    Quick Ratio
    		 0.99 0.87 2.29 4.02
    Current Ratio
    		 1.37 1.29 2.67 4.48
    Asset Turnover
    		 0.97 0.57 0.30 0.21
    Interest Coverage
    		 0.92 -2.64 -3.16 -4.89
    Return on Equity
    		 0.13 0.46 0.21 0.29
    Return on Assets
    		 -0.15 -1.02 -1.16 -0.84
    Return on Invested Capital
    		 0.27 -1.81 -1.22 -0.84
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.79 0.63 0.64 0.82
    Net Profit Margin
    		 -0.16 -1.8 -3.81 -4.06
    Pretax Profit Margin
    		 -0.16 -1.8 -3.1 -3.43
    Operating Profit Margin
    		 0.16 -1.34 -2.38 -2.89
    FCF Margin
    		 -0.07 -1.16 -2.32 -3.36
    EBITDA Margin
    		 0.02 -1.29 -2.34 -2.83

    Add to Watchlist